today provided the following letter to shareholders from the Company's, Chairman and CEO, Dr. Amit Kumar: Anixa Biosciences, Inc. (PRNewsfoto/Anixa Biosciences, Inc.) To our valued shareholders ...
The conversation gained traction when the CEO published an open letter defending the stipend ... I know the stipend is low, hence I try to offer other comforts like flexible hours.